Two Sigma Advisers »

Humacyte shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.3M 264k 4.80
2023-12-31 $145k 51k 2.84

More positions owned by Two Sigma Advisers

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Uber Technologies (UBER)
Mastercard Incorporated Cl A (MA)
Pfizer (PFE)
Crowdstrike Hldgs Cl A (CRWD)
Micron Technology (MU)
Abbott Laboratories (ABT)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Two Sigma Advisers

Top funds holding Humacyte

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Voloridge Investment Management
Nuveen Asset Management
Two Sigma Investments
Susquehanna International
Woodline Partners
Northern Trust
Goldman Sachs Group
Charles Schwab Investment Management
Marshall Wace
Monashee Investment Management

View all funds holding Humacyte